BTG1 and ovarian carcinoma: In the present study, BTG1 mRNA expression was negatively linked to FIGO staging of ovarian carcinoma, indicating that BTG1 protein might be involved in the development of ovarian cancer and may be considered a good biomarker for indicating the aggressive behaviors of ovarian carcinoma.